86-4062-34 [取扱停止]Mouse anti-EMA Monoclonal Antibody 20uL RD70630A
[Reddot Biotech] Mouse anti-EMA Monoclonal Antibody 20uL
特徴
Background:CA15-3 is a mucin-like glycoprotein, which is mainly used for research of breast cancer and has a reference value to the diagnosis of metastatic breast cancer, and it can also be used for other malignant tumors such as lung cancer, ovarian carcinoma. CA15-3 may be expressed in a few of benign breast tumors and ovarian tumors, but it differs in positive distribution of immunohistochemistry staining, which should be paid attention to take observation and judgment.
仕様
Synonyms:ADMCKD,ADMCKD1,Breast carcinoma associated antigen DF3,Breast carcinoma-associated antigen DF3,CA 15-3,CA15 3,CA15 3 antigen,CA15.3,Cancer antigen 15-3,Carcinoma associated mucin,Carcinoma-associated mucin,CD 227,CD227,DF3 antigen,EMA,Episialin,H23 antigen,H23AG,KL 6,KL-6,KL6,Krebs von den Lungen-6,MAM 6,MAM6,MCD,MCKD,MCKD1,Medullary cystic kidney disease 1 (autosomal dominant),Medullary cystic kidney disease,autosomal dominant,MUC 1,MUC-1,MUC-1/SEC,MUC-1/X,MUC1,MUC1-alpha,MUC1-beta,MUC1-CT,MUC1-NT,MUC1/ZD,MUC1,Mucin 1,Mucin 1 transmembrane,Mucin 1,cell surface associated,Mucin-1 subunit beta,Peanut reactive urinary mucin,Peanut-reactive urinary mucin,PEM,PEMT,Polymorphic epithelial mucin,PUM,Tumor associated epithelial membrane antigen,Tumor associated epithelial mucin,Tumor associated mucin,Tumor-associated epithelial membrane antigen,Tumor-associated mucin
Host:Mouse
Reactivity:Human
Applications:IHC-p
Concentration:1mg/mL
Immunogen:Full length protein from eukaryotic expression system.
Purification Method:Affinity purification
Clonality:Monoclonal
Clone No.:LE7G1
Conjugation:Unconjugated
Buffer:PBS with 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Dilution:IHC 1:100-1:200
Swissprot:P15941
Isotype:IgG
Research Areas:Cancer, Immunology, Signal transduction, Tags and Cell markers
サイズ:20uL
この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
【試薬に関するお問合せ】
アズワン株式会社 試薬・プロセス材料グループ
TEL:06-6447-8641
FAX:06-6447-8642
E-mail:[email protected]